Substrates for peptidase M16.002: insulysin
Peptide and protein substrates that are thought to be physiologically relevant are indicated by P. Peptide and protein substrates that are thought to be pathologically relevant are indicated by D. Peptide and protein substrates that are not physiologically relevant are indicated by N. Synthetic substrates are indicated by S. Click on the symbol to show only physiological, non-physiological or synthetic substrates, or here to display all substrates. How cleavage sites have been identified are indicated by the following evidence codes: NT = N-terminal sequencing, MS = mass spectroscopy, MU = mutation, CS = consensus sequence, LC = liquid chromatography. To see all annotated cleavages for a protein substrate, click on the UniProt Accession.
| Substrate | Uniprot | Residue range | Cleavage Site | Cleavage type | Evidence | P4 | P3 | P2 | P1 | P1' | P2' | P3' | P4' | Reference | CutDB | MERNUM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| amyloid beta A4 protein | P05067 | 672-713 | peptide-His684+His-peptide | N | Tyr | Glu | Val | His | His | Gln | Lys | Leu | Yan et al., 2006 | |||
| amyloid beta A4 protein | P05067 | 672-713 | peptide-His685+Gln-peptide | N | Glu | Val | His | His | Gln | Lys | Leu | Val | Yan et al., 2006 | |||
| amyloid beta A4 protein | P05067 | 672-713 | peptide-Gln686+Lys-peptide | N | Val | His | His | Gln | Lys | Leu | Val | Phe | Yan et al., 2006 | |||
| amyloid beta A4 protein | P05067 | 672-713 | peptide-Lys687+Leu-peptide | N | His | His | Gln | Lys | Leu | Val | Phe | Phe | Yan et al., 2006 | |||
| amyloid beta A4 protein | P05067 | 672-713 | peptide-Leu688+Val-peptide | N | His | Gln | Lys | Leu | Val | Phe | Phe | Ala | Yan et al., 2006 | |||
| amyloid beta A4 protein | P05067 | 672-713 | peptide-Val689+Phe-peptide | N | Gln | Lys | Leu | Val | Phe | Phe | Ala | Glu | Yan et al., 2006 | |||
| amyloid beta A4 protein | P05067 | 672-713 | peptide-Phe690+Phe-peptide | N | Lys | Leu | Val | Phe | Phe | Ala | Glu | Asp | Yan et al., 2006 | |||
| amyloid beta A4 protein | P05067 | 18-770 | peptide-Lys699+Gly-peptide | N | Gly | Ser | Asn | Lys | Gly | Ala | Ile | Ile | Yan et al., 2006 | |||
| atrial natriuretic factor | P01160 | 124-151 | Ser-Leu-Arg+Arg-peptide | N | - | Ser | Leu | Arg | Arg | Ser | Ser | Cys | Cornista et al., 2004 | |||
| atrial natriuretic factor | P01160 | 124-151 | peptide-Cys7+Phe-peptide | N | Arg | Ser | Ser | Cys | Phe | Gly | Gly | Arg | Cornista et al., 2004 | |||
| atrial natriuretic factor | P01160 | 124-151 | peptide-Asp13+Arg-peptide | N | Gly | Arg | Met | Asp | Arg | Ile | Gly | Ala | Cornista et al., 2004 | |||
| atrial natriuretic factor | P01160 | 124-151 | peptide-Ser25+Phe-Arg-Tyr | N | Gly | Cys | Asn | Ser | Phe | Arg | Tyr | - | Cornista et al., 2004 | |||
| beta-amyloid protein 42 | P05067 | 672-713 | peptide-Glu674+Phe-peptide | P | - | Asp | Ala | Glu | Phe | Arg | His | Asp | Yan et al., 2006 | |||
| beta-amyloid protein 42 | P05067 | 672-713 | peptide-Phe675+Arg-peptide | P | Asp | Ala | Glu | Phe | Arg | His | Asp | Ser | Yan et al., 2006 | |||
| beta-amyloid protein 42 | P05067 | 672-713 | peptide-Val683+His-peptide | P | NT | Gly | Tyr | Glu | Val | His | His | Gln | Lys | Malito et al., 2008 | ||
| beta-amyloid protein 42 | P05067 | 672-713 | peptide-Phe691+Ala-peptide | P | NT | Leu | Val | Phe | Phe | Ala | Glu | Asp | Val | Malito et al., 2008 | ||
| beta-amyloid protein 42 | P05067 | 672-713 | peptide-His684+His-peptide | P | MS | Tyr | Glu | Val | His | His | Gln | Lys | Leu | Yan et al., 2006 | ||
| beta-amyloid protein 42 | P05067 | 672-713 | peptide-His685+Gln-peptide | P | MS | Glu | Val | His | His | Gln | Lys | Leu | Val | Yan et al., 2006 | ||
| beta-amyloid protein 42 | P05067 | 672-713 | peptide-Gln686+Lys-peptide | P | MS | Val | His | His | Gln | Lys | Leu | Val | Phe | Yan et al., 2006 | ||
| beta-amyloid protein 42 | P05067 | 672-713 | peptide-Lys687+Leu-peptide | P | MS | His | His | Gln | Lys | Leu | Val | Phe | Phe | Yan et al., 2006 | ||
| beta-amyloid protein 42 | P05067 | 672-713 | peptide-Leu688+Val-peptide | P | MS | His | Gln | Lys | Leu | Val | Phe | Phe | Ala | Yan et al., 2006 | ||
| beta-amyloid protein 42 | P05067 | 672-713 | peptide-Val689+Phe-peptide | P | MS | Gln | Lys | Leu | Val | Phe | Phe | Ala | Glu | Yan et al., 2006 | ||
| beta-amyloid protein 42 | P05067 | 672-713 | peptide-Phe690+Phe-peptide | P | MS | Lys | Leu | Val | Phe | Phe | Ala | Glu | Asp | Yan et al., 2006 | ||
| beta-amyloid protein 42 | P05067 | 672-713 | peptide-Lys699+Gly-peptide | P | MS | Gly | Ser | Asn | Lys | Gly | Ala | Ile | Ile | Yan et al., 2006 | ||
| beta-endorphin | P01189 | 237-267 | peptide-Phe18+Lys-peptide | N | Val | Thr | Leu | Phe | Lys | Asn | Ala | Ile | Cornista et al., 2004 | |||
| beta-endorphin | P01189 | 237-267 | peptide-Leu17+Phe-peptide | N | Leu | Val | Thr | Leu | Phe | Lys | Asn | Ala | Cornista et al., 2004 | |||
| Bradykinin | P01042 | 381-389 | peptide-Pro387+Phe-Arg | N | MS | Gly | Phe | Ser | Pro | Phe | Arg | - | - | Malito et al., 2008 | ||
| brain natriuretic peptide | P07634 | 105-131 | peptide-Gly111+Arg-peptide | P | Gly | Cys | Phe | Gly | Arg | Arg | Leu | Asp | Müller et al., 1992 | 18771 | ||
| brain natriuretic peptide | P07634 | 105-131 | peptide-Asp115+Arg-peptide | P | Arg | Arg | Leu | Asp | Arg | Ile | Gly | Ser | Müller et al., 1992 | 18772 | ||
| brain natriuretic peptide | P07634 | 105-131 | peptide-Arg129+Arg-peptide | P | Asn | Val | Leu | Arg | Arg | Tyr | Gly | Gly | Müller et al., 1992 | 18773 | ||
| dynorphin A(1-13) | P01214 | 209-221 | Tyr-Gly-Gly-Phe-Leu-Arg+Arg-Ile-Arg-Pro-Lys-Leu-Lys | N | Gly | Phe | Leu | Arg | Arg | Ile | Arg | Pro | Roth, 2004 | |||
| insulin | P01317 | 25-54,85-105 | peptide-Ser33+His-peptide | P | Leu | Cys | Gly | Ser | His | Leu | Val | Glu | Malito et al., 2008 | |||
| insulin | P01317 | 25-54,85-105 | peptide-His34+Leu-peptide | P | Cys | Gly | Ser | His | Leu | Val | Glu | Ala | Malito et al., 2008 | |||
| insulin | P01317 | 25-54,85-105 | peptide-Ala38+Leu-peptide | P | Leu | Val | Glu | Ala | Leu | Tyr | Leu | Val | Malito et al., 2008 | |||
| insulin | P01317 | 25-54,85-105 | peptide-Phe48+Phe-peptide | N | Glu | Arg | Gly | Phe | Phe | Tyr | Thr | Pro | Malito et al., 2008 | |||
| insulin | P01317 | 25-54,85-105 | peptide-Phe49+Tyr-peptide | P | Arg | Gly | Phe | Phe | Tyr | Thr | Pro | Lys | Malito et al., 2008 | |||
| insulin | P01317 | 25-54,85-105 | peptide-Leu97+ | P | Val | Cys | Ser | Leu | - | - | - | - | Malito et al., 2008 | |||
| insulin | P01317 | 25-54,85-105 | peptide-Tyr98+ | P | Cys | Ser | Leu | Tyr | - | - | - | - | Malito et al., 2008 | |||
| insulin | P01308 | 25-54,90-110 | peptide-Ser33+His-peptide | P | MS | Leu | Cys | Gly | Ser | His | Leu | Val | Glu | Guo et al., 2009 | ||
| insulin | P01308 | 25-54,90-110 | peptide-His34+Leu-peptide | P | MS | Cys | Gly | Ser | His | Leu | Val | Glu | Ala | Guo et al., 2009 | ||
| insulin | P01308 | 25-54,90-110 | peptide-Glu37+Ala-peptide | P | MS | His | Leu | Val | Glu | Ala | Leu | Tyr | Leu | Guo et al., 2009 | ||
| insulin | P01308 | 25-54,90-110 | peptide-Ala38+Leu-peptide | P | MS | Leu | Val | Glu | Ala | Leu | Tyr | Leu | Val | Guo et al., 2009 | ||
| insulin | P01308 | 25-54,90-110 | peptide-Phe48+Phe-peptide | P | MS | Glu | Arg | Gly | Phe | Phe | Tyr | Thr | Pro | Guo et al., 2009 | ||
| insulin | P01308 | 25-54,90-110 | peptide-Phe49+Tyr-peptide | P | MS | Arg | Gly | Phe | Phe | Tyr | Thr | Pro | Lys | Guo et al., 2009 | ||
| insulin | P01308 | 25-54,90-110 | peptide-Leu102+Tyr-peptide | P | MS | Ile | Cys | Ser | Leu | Tyr | Gln | Leu | Glu | Guo et al., 2009 | ||
| insulin | P01308 | 25-54,90-110 | peptide-Tyr103+Gln-peptide | P | MS | Cys | Ser | Leu | Tyr | Gln | Leu | Glu | Asn | Guo et al., 2009 | ||
| insulin B-chain (oxidized) | P01317 | 25-54 | Phe-Val-Asn-Gln-His-Leu-Cya-Gly-Ser-His-Leu-Val-Glu+Ala-Leu-Tyr-Leu-Val-Cya-Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys-Ala | N | His | Leu | Val | Glu | Ala | Leu | Tyr | Leu | Roth, 2004 | |||
| insulin B-chain (oxidized) | P01317 | 25-54 | Phe-Val-Asn-Gln-His-Leu-Cya-Gly-Ser-His-Leu-Val-Glu-Ala-Leu-Tyr+Leu-Val-Cya-Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys-Ala | N | Glu | Ala | Leu | Tyr | Leu | Val | Cya | Gly | Roth, 2004 | |||
| insulin-like growth factor II | P01344 | 25-91 | peptide-Thr40+Leu-peptide | P | MS | Leu | Val | Asp | Thr | Leu | Gln | Phe | Val | Guo et al., 2009 | ||
| insulin-like growth factor II | P01344 | 25-91 | peptide-Gln42+Phe-peptide | P | MS | Asp | Thr | Leu | Gln | Phe | Val | Cys | Gly | Guo et al., 2009 | ||
| insulin-like growth factor II | P01344 | 25-91 | peptide-Phe50+Tyr-peptide | P | MS | Asp | Arg | Gly | Phe | Tyr | Phe | Ser | Arg | Guo et al., 2009 | ||
| insulin-like growth factor II | P01344 | 25-91 | peptide-Tyr51+Phe-peptide | P | MS | Arg | Gly | Phe | Tyr | Phe | Ser | Arg | Pro | Guo et al., 2009 | ||
| insulin-like growth factor II | P01344 | 25-91 | peptide-Phe52+Ser-peptide | P | MS | Gly | Phe | Tyr | Phe | Ser | Arg | Pro | Ala | Guo et al., 2009 | ||
| insulin-like growth factor II | P01344 | 25-91 | peptide-Ser60+Arg-peptide | P | MS | Ser | Arg | Val | Ser | Arg | Arg | Ser | Arg | Guo et al., 2009 | ||
| insulin-like growth factor II | P01344 | 25-91 | peptide-Arg61+Arg-peptide | P | MS | Arg | Val | Ser | Arg | Arg | Ser | Arg | Gly | Guo et al., 2009 | ||
| insulin-like growth factor II | P01344 | 25-91 | peptide-Cys71+Phe-peptide | P | MS | Glu | Glu | Cys | Cys | Phe | Arg | Ser | Cys | Guo et al., 2009 | ||
| insulin-like growth factor II | P01344 | 25-91 | peptide-Phe72+Arg-peptide | P | MS | Glu | Cys | Cys | Phe | Arg | Ser | Cys | Asp | Guo et al., 2009 | ||
| insulin-like growth factor II | P01344 | 25-91 | peptide-Pro87+Ala-peptide | P | MS | Cys | Ala | Thr | Pro | Ala | Lys | Ser | Glu | Guo et al., 2009 | ||
| insulin-like growth factor II | P01344 | 25-91 | peptide-Ala88+Lys-Ser-Glu | P | MS | Ala | Thr | Pro | Ala | Lys | Ser | Glu | - | Guo et al., 2009 | ||
| natriuretic peptide precursor C | P18104 | 105-126 | peptide-Gly112+Leu-peptide | P | Gly | Cys | Phe | Gly | Leu | Lys | Leu | Asp | Müller et al., 1992 | 18774 | ||
| natriuretic peptide precursor C | P18104 | 105-126 | peptide-Asp116+Arg-peptide | P | Leu | Lys | Leu | Asp | Arg | Ile | Gly | Ser | Müller et al., 1992 | 18775 | ||
| natriuretic peptide precursor type A | P01161 | 122-150 | peptide-Arg125+Arg-peptide | P | Arg | Ser | Leu | Arg | Arg | Ser | Ser | Cys | Müller et al., 1992 | 18767 | ||
| natriuretic peptide precursor type A | P01161 | 122-150 | peptide-Cys129+Phe-peptide | P | Arg | Ser | Ser | Cys | Phe | Gly | Gly | Arg | Müller et al., 1992 | 18768 | ||
| natriuretic peptide precursor type A | P01161 | 122-150 | peptide-Asp135+Arg-peptide | P | Gly | Arg | Ile | Asp | Arg | Ile | Gly | Ala | Müller et al., 1992 | 18769 | ||
| natriuretic peptide precursor type A | P01161 | 122-150 | peptide-Ser147+Phe-peptide | P | Gly | Cys | Asn | Ser | Phe | Arg | Tyr | Arg | Müller et al., 1992 | 18770 | ||
| polyubiquitin-B | P0CG47 | 1-76 | peptide-Arg74+Gly-Gly | P | Ms | Leu | Arg | Leu | Arg | Gly | Gly | - | - | Ralat et al., 2011 | ||
| polyubiquitin-B | P0CG47 | 1-74 | peptide-Arg72+Leu-Arg | P | MS | Leu | Val | Leu | Arg | Leu | Arg | - | - | Ralat et al., 2011 | ||
| polyubiquitin-B | P0CG47 | 77-152 | peptide-Arg150+Gly-Gly | P | MS | Leu | Arg | Leu | Arg | Gly | Gly | - | - | Ralat et al., 2011 | ||
| polyubiquitin-B | P0CG47 | 77-150 | peptide-Arg148+Leu-Arg | P | MS | Leu | Val | Leu | Arg | Leu | Arg | - | - | Ralat et al., 2011 | ||
| polyubiquitin-B | P0CG47 | 153-228 | peptide-Arg226+Gly-Gly | P | MS | Leu | Arg | Leu | Arg | Gly | Gly | - | - | Ralat et al., 2011 | ||
| polyubiquitin-B | P0CG47 | 153-226 | peptide-Arg224+Leu-Arg | P | MS | Leu | Val | Leu | Arg | Leu | Arg | - | - | Ralat et al., 2011 | ||
| polyubiquitin-C | P0CG48 | 1-76 | peptide-Arg74+Gly-Gly | N | MS | Leu | Arg | Leu | Arg | Gly | Gly | - | - | Ralat et al., 2011 | ||
| polyubiquitin-C | P0CG48 | 1-74 | peptide-Arg72+Leu-Arg | P | MS | Leu | Val | Leu | Arg | Leu | Arg | - | - | Ralat et al., 2011 | ||
| polyubiquitin-C | P0CG48 | 77-152 | peptide-Arg150+Gly-Gly | P | MS | Leu | Arg | Leu | Arg | Gly | Gly | - | - | Ralat et al., 2011 | ||
| polyubiquitin-C | P0CG48 | 77-150 | peptide-Arg148+Leu-Arg | P | MS | Leu | Val | Leu | Arg | Leu | Arg | - | - | Ralat et al., 2011 | ||
| polyubiquitin-C | P0CG48 | 153-228 | peptide-Arg226+Gly-Gly | P | MS | Leu | Arg | Leu | Arg | Gly | Gly | - | - | Ralat et al., 2011 | ||
| polyubiquitin-C | P0CG48 | 153-226 | peptide-Arg224+Leu-Arg | P | MS | Leu | Val | Leu | Arg | Leu | Arg | - | - | Ralat et al., 2011 | ||
| polyubiquitin-C | P0CG48 | 229-304 | peptide-Arg302+Gly-Gly | P | MS | Leu | Arg | Leu | Arg | Gly | Gly | - | - | Ralat et al., 2011 | ||
| polyubiquitin-C | P0CG48 | 229-302 | peptide-Arg300+Leu-Arg | P | MS | Leu | Val | Leu | Arg | Leu | Arg | - | - | Ralat et al., 2011 | ||
| polyubiquitin-C | P0CG48 | 305-380 | peptide-Arg378+Gly-Gly | P | MS | Leu | Arg | Leu | Arg | Gly | Gly | - | - | Ralat et al., 2011 | ||
| polyubiquitin-C | P0CG48 | 305-378 | peptide-Arg376+Leu-Arg | P | MS | Leu | Val | Leu | Arg | Leu | Arg | - | - | Ralat et al., 2011 | ||
| polyubiquitin-C | P0CG48 | 381-456 | peptide-Arg454+Gly-Gly | P | MS | Leu | Arg | Leu | Arg | Gly | Gly | - | - | Ralat et al., 2011 | ||
| polyubiquitin-C | P0CG48 | 381-454 | peptide-Arg452+Leu-Arg | P | MS | Leu | Val | Leu | Arg | Leu | Arg | - | - | Ralat et al., 2011 | ||
| polyubiquitin-C | P0CG48 | 457-532 | peptide-Arg530+Gly-Gly | P | MS | Leu | Arg | Leu | Arg | Gly | Gly | - | - | Ralat et al., 2011 | ||
| polyubiquitin-C | P0CG48 | 457-530 | peptide-Arg528+Leu-Arg | P | MS | Leu | Val | Leu | Arg | Leu | Arg | - | - | Ralat et al., 2011 | ||
| polyubiquitin-C | P0CG48 | 533-608 | peptide-Arg606+Gly-Gly | P | MS | Leu | Arg | Leu | Arg | Gly | Gly | - | - | Ralat et al., 2011 | ||
| polyubiquitin-C | P0CG48 | 533-606 | peptide-Arg604+Leu-Arg | P | MS | Leu | Val | Leu | Arg | Leu | Arg | - | - | Ralat et al., 2011 | ||
| polyubiquitin-C | P0CG48 | 609-684 | peptide-Arg682+Gly-Gly | P | MS | Leu | Arg | Leu | Arg | Gly | Gly | - | - | Ralat et al., 2011 | ||
| polyubiquitin-C | P0CG48 | 609-682 | peptide-Arg680+Leu-Arg | P | MS | Leu | Val | Leu | Arg | Leu | Arg | - | - | Ralat et al., 2011 | ||
| protransforming growth factor alpha | P01135 | 40-89 | peptide-Ser50+His-peptide | P | MS | Cys | Pro | Asp | Ser | His | Thr | Gln | Phe | Guo et al., 2009 | ||
| protransforming growth factor alpha | P01135 | 40-89 | peptide-Gln53+Phe-peptide | P | MS | Ser | His | Thr | Gln | Phe | Cys | Phe | His | Guo et al., 2009 | ||
| protransforming growth factor alpha | P01135 | 40-89 | peptide-Phe54+Cys-peptide | P | MS | His | Thr | Gln | Phe | Cys | Phe | His | Gly | Guo et al., 2009 | ||
| protransforming growth factor alpha | P01135 | 40-89 | peptide-Phe56+His-peptide | P | MS | Gln | Phe | Cys | Phe | His | Gly | Thr | Cys | Guo et al., 2009 | ||
| protransforming growth factor alpha | P01135 | 40-89 | peptide-Thr59+Cys-peptide | P | MS | Phe | His | Gly | Thr | Cys | Arg | Phe | Leu | Guo et al., 2009 | ||
| protransforming growth factor alpha | P01135 | 40-89 | peptide-Cys60+Arg-peptide | P | MS | His | Gly | Thr | Cys | Arg | Phe | Leu | Val | Guo et al., 2009 | ||
| protransforming growth factor alpha | P01135 | 40-89 | peptide-Cys73+His-peptide | P | MS | Ala | Cys | Val | Cys | His | Ser | Gly | Tyr | Guo et al., 2009 | ||
| protransforming growth factor alpha | P01135 | 40-89 | peptide-His74+Ser-peptide | P | MS | Cys | Val | Cys | His | Ser | Gly | Tyr | Val | Guo et al., 2009 | ||
| protransforming growth factor alpha | P01135 | 40-89 | peptide-Gly79+Ala-peptide | P | MS | Gly | Tyr | Val | Gly | Ala | Arg | Cys | Glu | Guo et al., 2009 | ||
| somatostatin-14 | P61278 | 103-116 | peptide-Phe108+Phe-peptide | P | Cys | Lys | Asn | Phe | Phe | Trp | Lys | Thr | Ciacco et al., 2008 | |||
| vasoactive intestinal peptide | His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu+Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2 | N | Tyr | Thr | Arg | Leu | Arg | Lys | Gln | Met | Cornista et al., 2004 | |||||
| [Lys]-bradykinin (kallidin) | P01042 | 380-389 | peptide-Pro387+Phe-Arg | N | MS | Gly | Phe | Ser | Pro | Phe | Arg | - | - | Malito et al., 2008 |
